Inventor

LANGE UDO

DE48 patents

⚠️ This page may combine multiple inventors who share the name “LANGE UDO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LANGE UDO

ABBVIE DEUTSCHLAND

Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors

Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy

N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy

4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy

Fused (hetero)cyclic compounds as S1P modulators

Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy

Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy

ABBOTT GMBH & CO KG

Thrombin inhibitors

3-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereof

Integrin receptors antagonists

Integrin receptor ligands

Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

Integrin ligands

Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

AMBERG WILHELM

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

Heterocyclic compounds and their use as binding partners for 5-HT5 receptors

5-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptors

Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy

Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy

Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-HT5-receptors

POHLKI FRAUKE

Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

TURNER SEAN COLM

Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor

Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor

LANGE UDO

Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy

Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy

NETZ ASTRID

Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors

Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors

ABBOTT LAB

Dipeptide benzamidine as a kininogenase inhibitor

Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

BASF AG

Thrombin inhibitors

Process for preparing 3-pyrroline-2-carboxylic acid derivatives

GRANDEL ROLAND

Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor

Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor

OTIS ENG CO

Sand screen for production oil wells

OCHSE MICHAEL

Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy

ABBVIE INC

Fused heterocyclic compounds as S1P modulators

BRAJE WILFRIED

1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

SCHULTZ THOMAS

Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor